Immuno-oncology company Agenus to cut 50 jobs in reorganization

This article was originally published here

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply